The nation of Zimbabwe has declined a substantial American health deal valued at $367m (£272m) over five years because of Washington's request for sensitive data.
This rejection came to light following a government memo dated December was leaked, which showed Head of State Emmerson Mnangagwa felt the deal was "unbalanced".
An official spokesperson has since clarified that the United States was requesting health data for scientific study and commercial purposes but refused to guarantee the resulting advantages from future treatments.
"We will now turn to the challenging and unfortunate task of winding down our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had provided more than $1.9bn in health funding to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has appealed for more negotiations to reach a agreement agreeable to both sides so the nation's critical HIV treatment initiative can be sustained.
Broader Background
This rejection comes after a comparable case in neighbouring Kenya, where a high court halted a similar health funding agreement after legal challenges were raised about the safety of citizens' health data.
Since returning to the presidency last year, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.
USAID had managed aid for the American government, but Trump claimed its expenditure was "inefficient" and his administration was pursuing government-to-government deals to boost openness and responsibility.
Based on statements, 16 African countries have to date signed these new health pacts, constituting over $18.3bn of fresh investment.
Details of the Rejected Deal
This assistance for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"It is our view this collaboration would have delivered extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving HIV treatment via US-supported initiatives," Tremont added.
However, government spokesperson Nick Mangwana said the proposed deal was "unequal".
"Zimbabwe was being asked to surrender its biological resources and data over an extended period, with no corresponding assurance of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that provided information," he stated.
"Put simply, our country would supply the basic resources for scientific discovery with no certainty that the end products would be available to our people if a future health crisis emerge."
National Interest and International Frameworks
Mangwana further pointed out that the US's withdrawal from the global health body and its push of one-on-one health agreements were undermining systems previously established through the international health agency.
Mangwana cited its Pandemic Benefit-Sharing framework designed to manage future pandemics.
"This system is intended to guarantee that when a country contributes its data, the benefits – including medicines and cures – are shared equitably, not commercialised solely by those with the resources to create them."
The government's concerns regarding the US deal "must not be interpreted as opposition to America," he added.
"We encourage ongoing discussions with our US partners on how future collaboration could be arranged in a way that honours the sovereignty and interests of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the government's concerns, but recommended that talks need to persist considering a large portion of the nation's HIV programmes depended on international support.
"In cases where specific concerns arise, such as those relating to information security or agreement terms, these can frequently be resolved through detailed discussion and negotiated safeguards," it said.
This impasse underscores the ongoing tensions between receiving much-needed international aid and safeguarding national sovereignty in an increasingly data-driven world.